Thyroid Gland Adenocarcinoma — Trials

Thyroid Gland Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

195 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 43
Recruiting: 17
Ph III recruiting: 4
Growth YoY: —
Industry share: 7%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 25.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (13)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06261190	Active Surveillance for Low-risk Papillary Thyroid Carcinoma(MAeSTro-EXP)	enrolling by invitation	—	499	National Cancer Center, KoreaOTHER_GOV	1	May 11, 2025	clinicaltrials

Data updated 22 days agoSource updated May 11, 2025source: clinicaltrials